Amicus Therapeutics, Inc. (FOLD) - Pendapatan perusahaan

Amicus Therapeutics (FOLD) leverages the digitalization of bioanalysis and AI to drive efficiency and reduce costs. The company's commercial revenue clearly confirms this growth, with the indicator currently standing at 0.63. Development relies on partnerships with geneticists and patient funds. High margins from monopoly products within the narrow niche of rare metabolic pathologies ensure the long-term financial stability of the business.

FOLD Amicus Corp: Pendapatan perusahaan ing interval 04.07.2022 - 09.05.2026

Rincian analitis perusahaan Amicus Therapeutics

- rega lan prakiraan konsensus rega:

Rega saham Amicus Corp|FOLD - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Nilai pasar Amicus Therapeutics, Inc.|FOLD - Nilai Total Perusahaan

- informasi kapitalisasi buku:

Nilai Aset Bersih saben Saham Amicus Therapeutics|FOLD - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku amicusrx.com|FOLD - Total Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Koefisien Total Utang marang Modal Amicus Therapeutics|FOLD - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Amicus Therapeutics Inc|FOLD - Utang perusahaan|Utang marang nilai buku Amicus Therapeutics, Inc.|FOLD - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Amicus Therapeutics|Indikator likuiditas cepet amicusrx.com

- data bathi bisnis lan rasio investasi:

FOLD - Bathi resik|Prakiraan bathi perusahaan Amicus Therapeutics|FOLD - Pangali P/E|Prakiraan rega marang bathi amicusrx.com|FOLD - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Amicus Therapeutics, Inc.|FOLD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Amicus Therapeutics|FOLD - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan amicusrx.com|FOLD - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Amicus Therapeutics

- indikator volume dodolan lan pendapatan:

FOLD - Pendapatan lan volume dodolan|Pendapatan mangsa ngarep perusahaan Amicus Corp|FOLD - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Amicus Therapeutics, Inc.

Analisis komprehensif perusahaan:FOLD Amicus Corp

Amicus Therapeutics (FOLD) specializes in therapies for rare metabolic pathologies, ensuring high margins through its monopoly position, which directly drives revenue dynamics. By analyzing the company's sales volume on the GURU.Markets platform, investors can assess the aggregate cash flow from sales, which helps mitigate US market cycle risks and confirms sustained demand for its unique drugs.

Pesaing wigati